Ikke-småcellet lungekræft scenemigration som en funktion af ventetider fra diagnostisk billeddannelse: En samlet analyse fra fem internationale centre
Introduction: Sufferers with non-small cell lung most cancers (NSCLC) can expertise speedy illness development between preliminary staging FDG-PET scans and graduation of curative-intent radiotherapy (RT). Earlier research that estimated stage migration charges by evaluating staging PET/CT and treatment-planning PET/CT photos had been restricted by small pattern sizes.
Strategies: This multicenter, worldwide examine mixed potential knowledge from 5 establishments for PET-staged sufferers with NSCLC who had been meant to obtain curative-intent RT. TNM standing was in contrast for staging and RT planning scans and the likelihood of TNM standing and general stage migration was analyzed as a operate of the interval between PET/CT scans. The impacts of N classification, general stage, and pathology had been additionally studied.
Outcomes: Pooled knowledge from 181 sufferers had been analyzed.
The median interval between PET/CT scans was 42 days (vary, 2-208). Upstaging occurred in 32 % of sufferers. The general fee of stage migration was larger for sufferers presenting with preliminary stage IIIB/IIIC illness (p = 0.006) and sufferers with N2-Three nodal illness (p = 0.019). Upstaging to M1 illness was considerably related to preliminary stage IIIB/IIIC illness (HR = 15.2) and adenocarcinoma (HR = 10) histology.
Conclusion: Longer intervals between imaging and remedy in sufferers with NSCLC had been related to excessive charges illness development with consequent dangers of geographic miss in RT planning and futile remedy in sufferers with M1 illness. Sufferers with extra intensive preliminary nodal involvement and people with adenocarcinoma had the best charges of stage migration. Devoted RT planning PET/CT imaging is really useful, particularly if >Three weeks have elapsed after preliminary staging.
Key phrases: Illness development; Regionally-advanced non-small cell lung most cancers; PET/CT imaging; Stage migration.
Kortere forsinkelse af behandlingen af integrerede diagnostiske tjenester og støtte fra NGO’er blandt brystkræftpatienter i to brasilianske henvisningscentre
Background: The prognosis of breast most cancers requires a sophisticated sequence of diagnostic exams. The current examine addressed the delay of sufferers who used publicly and privately financed diagnostic providers. Non-governmental organizations (NGOs) donated diagnostic mammograms and biopsies.
Design and strategies: Knowledge from 304 sufferers had been obtained from two Brazilian referral centres. In a single referral centre (FAP), diagnostic mammography, clinic-histopathological examination and immunohistochemistry had been outsourced, whereas within the different centre (HNL), these providers had been built-in. Cox regression, Kaplan-Meier evaluation and non-parametric checks had been used to match variables and time intervals.
Outcomes: If diagnostic mammography was financed privately and coated by non-public medical health insurance, the probability of a delay of >90 days between the primary medical go to and the initiation of remedy decreased 2.15-fold (95%CI: 1.06- 4.36; p=0.033) and 4.44-fold (95%CI: 1.58-12.46; p=0.004), respectively.
If the clinic-histopathological examination was outsourced (FAP) and publicly or privately financed, the median time between diagnostic mammography and the diagnostic end result was 53 and 65 days within the built-in (HNL) and outsourced public system, in comparison with 29 days within the outsourced non-public system (p<0.050).
The median time between the primary medical go to and the diagnostic outcomes of sufferers who had been supported by NGOs, who financed their diagnostic providers privately, and who used solely public diagnostic providers was, respectively, 28.0, 48.5 and 77.5 days (p<0.050).
Conclusion: Sufferers who used privately financed well being providers had shorter delays. In comparison with outsourcing, the combination of the publicly financed clinic-histopathological examination diminished the delay. The assist of sufferers by NGOs accelerated affected person circulation.
 Bead Sample Pack - 50mL Set |
|||
| BSP-50B2 | Next Advance | 1pack | EUR 404 |
|
Description: Bead sample pack for Bullet Blender 50mL tube models. Includes 20mL of: ZROB05, ZROB20, SSB02, SSB14B, SSB48, SSB60, SSUFO35 and SSUFO56. |
|||
 Bead Sample Pack - 5E Set |
|||
| BSP-5E | Next Advance | 1pack | EUR 252 |
|
Description: Bead sample pack for Bullet Blender 5E models. Includes 10mL of: ZROB015, ZROB05, ZROB20, SSB02, SSB14B, SSB32, SSB48, SSUFO35 and SSUFO56. |
|||
 Bead Sample Pack - 5M Set |
|||
| BSP-5Y | Next Advance | 1pack | EUR 241 |
|
Description: Bead sample pack for Bullet Blender 5mL Storm models. Includes 10mL of: ZROB015, ZROB05, ZROB20, SSB02, SSB14B, SSB32, SSB60, SSB110 and SSUFO35. |
|||
 Bead Sample Pack - Full Set |
|||
| BSP-ALL2 | Next Advance | 1pack | EUR 384 |
|
Description: Bead sample pack inlcudes sampling of all 20 bead types in 10mL tubes. |
|||
 Bead Sample Pack - Microcentrifuge Set |
|||
| BSP-MC2 | Next Advance | 1pack | EUR 232 |
|
Description: Bead sample pack for Bullet Blender 1.5mL tube models. Includes 10mL of: ZROB015, ZROB05, ZROB10, ZROB20, SSB02, SSB14B, SSB32 and SSUFO35. |
|||
 Bead Sample Pack - Organ Tissues |
|||
| BSP-OT3 | Next Advance | 1pack | EUR 235 |
|
Description: Bead sample pack for homogenization of organ tissues. Includes 10mL of: ZROB05, ZROB10, ZROB20, SSB14B, SSB32 and SSUFO35. |
|||
 All Sample Diluents Sample Pack |
|||
| KF17355 | Neuromics | 3X100 ml | EUR 272 |
 Red Blood Cell Sample Pack |
|||
| 88R-1050 | Fitzgerald | 6 x 2 ml | EUR 403 |
|
Description: Horse, Mouse, Rabbit, Sheep, Bovine and Chicken glutaraldehyde stabilized blood cell samples |
|||
 sample) Exosome isolation Solution - Cell Media/ Urine (easy version of P100, 95% pure exosome) sample |
|||
| P100EZ-sample | 101Bio | NULL | EUR 0 |
 TMB Peroxidase Substrate SAMPLE PACK |
|||
| 42R-TB101 | Fitzgerald | 3 x 100 ml | EUR 300 |
|
Description: 100mL of 3 different TMB Peroxidase Substrates ready to use in immunoassays: Ultra sensitivite, Highly Sensitive, and Slow Acting. |
|||
 3 Blocking Buffer Sample Pack |
|||
| KF17340 | Neuromics | 3 x 100 ml | EUR 205 |
 All Assay Diluents Sample Pack |
|||
| KF17351 | Neuromics | 4X100 ml | EUR 272 |
 sample) Exosome isolation Solution - Serum/ Plasma (easy version of P101, 95% pure exosome) sample |
|||
| P101EZ--sample | 101Bio | NULL | EUR 0 |
 Water, 0.1um Filtered, cell cultures tested |
|||
| W0900-050 | GenDepot | 500 ml | EUR 68 |
Water, 0.1um Filtered, cell cultures tested |
|||
| W0900-310 | GenDepot | 10x500 ml | EUR 169 |
Water, 0.1um Filtered, cell cultures tested |
|||
| W0900-350 | GenDepot | 50x500 ml | EUR 523 |
 Micro Bead Sterlizer |
|||
| B1201-E | BenchMark | 1 PC | EUR 542.7 |
|
|||
Micro Bead Sterlizer |
|||
| B1202-E | BenchMark | 1 PC | EUR 84.14 |
|
|||
 Refill Glass Beads |
|||
| B1201-BEAD | BenchMark | 1 PC | EUR 117.78 |
|
|||
 Column Packing Kit |
|||
| PACK-KIT | Next Advance | 1pack | EUR 1035 |
|
Description: Column packing kit for pressure cells. Includes: HPREG regulator, TBNG10 tubing, CAP-75 capillary, and STRB5X2 stir bar. |
|||
 Sample Diluent |
|||
| I094 | Cygnus Technologies | 1000 ml | EUR 519 |
|
|||
|
Description: Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
Sample Diluent |
|||
| I094-100 | Cygnus Technologies | 100 ml | EUR 211 |
|
|||
|
Description: Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
Sample Diluent |
|||
| I094-500 | Cygnus Technologies | 500 ml | EUR 373 |
|
|||
|
Description: Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
 Bangs Lab Bead Solution |
|||
| SOLN1-1000 | Bangs Laboratories | 1000 ML | EUR 155.06 |
|
Description: Bangs Lab Bead Solution is ready-to-use solution and is suitable for dilution and/or storage of plain, dyed, or functionalized polymer microspheres |
|||
Bangs Lab Bead Solution |
|||
| SOLN1-2000 | Bangs Laboratories | 2000 ML | EUR 212.7 |
|
Description: Bangs Lab Bead Solution is ready-to-use solution and is suitable for dilution and/or storage of plain, dyed, or functionalized polymer microspheres |
|||
Bangs Lab Bead Solution |
|||
| SOLN1-500 | Bangs Laboratories | 500 ML | EUR 98.51 |
|
Description: Bangs Lab Bead Solution is ready-to-use solution and is suitable for dilution and/or storage of plain, dyed, or functionalized polymer microspheres |
|||
 Adapter pack |
|||
| C1005-AC2 | BenchMark | 1 PC | EUR 98.5 |
|
|||
Adapter pack |
|||
| C3100-ADP | BenchMark | 1 PC | EUR 164.18 |
|
|||
 EZ Pack |
|||
| A2501 | BenchMark | 1 PC | EUR 365.66 |
|
|||
EZ Pack |
|||
| A2505 | BenchMark | 1 PC | EUR 183.03 |
|
|||
 sample) Long-term Cell Tracer 580 (Green) sample |
|||
| P710GS | 101Bio | NULL | EUR 0 |
 sample) Long-term Cell Tracer 580 (Yellow) sample |
|||
| P710YS | 101Bio | NULL | EUR 0 |
 Sample diluent buffer |
|||
| AR1106-1 | BosterBio | 30ml | EUR 91 |
 Rotavirus Positive Sample |
|||
| DAG-H10377 | Creative Diagnostics | 1 ml dry ice | EUR 1105 |
 RSV Positive Sample |
|||
| DAG-H10378 | Creative Diagnostics | 1 ml dry ice | EUR 1105 |
 DNA Sample Diluent |
|||
| D006-100 | Cygnus Technologies | 100 ml | EUR 373 |
|
|||
|
Description: DNA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
DNA Sample Diluent |
|||
| D006-1000 | Cygnus Technologies | 1000 ml | EUR 1167 |
|
|||
|
Description: DNA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
DNA Sample Diluent |
|||
| D006-500 | Cygnus Technologies | 500 ml | EUR 726 |
|
|||
|
Description: DNA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
 Sample Diluent Buffer |
|||
| abx296001-20ml | Abbexa | 20 ml | EUR 91 |
|
|||
 BSA Sample Diluent |
|||
| F031A | Cygnus Technologies | 1000 ml | EUR 488 |
|
|||
|
Description: BSA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
BSA Sample Diluent |
|||
| F031A-100 | Cygnus Technologies | 100 ml | EUR 195 |
|
|||
|
Description: BSA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
BSA Sample Diluent |
|||
| F031A-500 | Cygnus Technologies | 500 ml | EUR 411 |
|
|||
|
Description: BSA Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
 Sample Denaturing Buffer |
|||
| F054 | Cygnus Technologies | 12 ml | EUR 195 |
|
|||
|
Description: Sample Denaturing Buffer by Cygnus Technologies is available in Europe via Gentaur. |
|||
 Sample Treatment Buffer |
|||
| F175 | Cygnus Technologies | 1000 ml | EUR 411 |
|
|||
|
Description: Sample Treatment Buffer by Cygnus Technologies is available in Europe via Gentaur. |
|||
Sample Treatment Buffer |
|||
| F175-100 | Cygnus Technologies | 100 ml | EUR 219 |
|
|||
|
Description: Sample Treatment Buffer by Cygnus Technologies is available in Europe via Gentaur. |
|||
 Sample Treatment Plate |
|||
| F402 | Cygnus Technologies | 1x 96 wells plate | EUR 103 |
|
|||
|
Description: Sample Treatment Plate by Cygnus Technologies is available in Europe via Gentaur. |
|||
 ELISA Sample Diluent |
|||
| ESD125 | ScyTek Laboratories | 125 ml | EUR 80 |
ELISA Sample Diluent |
|||
| ESD500 | ScyTek Laboratories | 500 ml | EUR 109 |
ELISA Sample Diluent |
|||
| ESD999 | ScyTek Laboratories | 1000 ml | EUR 157 |
Sample Diluent Buffer |
|||
| I028-100 | Cygnus Technologies | 100 ml | EUR 211 |
|
|||
|
Description: Sample Diluent Buffer by Cygnus Technologies is available in Europe via Gentaur. |
|||
Sample Diluent Buffer |
|||
| I028-1000 | Cygnus Technologies | 1000 ml | EUR 519 |
|
|||
|
Description: Sample Diluent Buffer by Cygnus Technologies is available in Europe via Gentaur. |
|||
Sample Diluent Buffer |
|||
| I028-500 | Cygnus Technologies | 500 ml | EUR 373 |
|
|||
|
Description: Sample Diluent Buffer by Cygnus Technologies is available in Europe via Gentaur. |
|||
 HEPES Sample Diluent |
|||
| I050 | Cygnus Technologies | 1000 ml | EUR 527 |
|
|||
|
Description: HEPES Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
HEPES Sample Diluent |
|||
| I050-100 | Cygnus Technologies | 100 ml | EUR 219 |
|
|||
|
Description: HEPES Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
HEPES Sample Diluent |
|||
| I050-500 | Cygnus Technologies | 500 ml | EUR 334 |
|
|||
|
Description: HEPES Sample Diluent by Cygnus Technologies is available in Europe via Gentaur. |
|||
 Sample Diluent, 60ML |
|||
| X028-60ML | Arbor Assays | 60ML | EUR 143 |
) Protein A Tell-Tale Gold Ribbon Sample Pack, 3 x (1 cm x 30 cm) |
|||
| TTGA-SP3-B090 | BioAssayWorks | 3 x (1 cm x 30 cm) | EUR 227.67 |
|
|||
|
Description: The pack contains polyester ribbon, which is soaked with 0.13 O.D./cm2 concentration with Protein G conjugated to gold nanoparticles. |
|||
) Protein G Tell-Tale Gold Ribbon Sample Pack, 3 x (1 cm x 30 cm) |
|||
| TTGG-SP3-B090 | BioAssayWorks | 3 x (1 cm x 30 cm) | EUR 227.67 |
|
|||
|
Description: The pack contains polyester ribbon, which is soaked with 3 different concentrations with Protein G conjugated to gold nanoparticles. |
|||
 DEAE Rapid Run Agarose Bead |
|||
| DEAERR-25 | ABTBeads | 25 ml | EUR 102 |
DEAE Rapid Run Agarose Bead |
|||
| DEAERR-300 | ABTBeads | 300 ml | EUR 492 |
 CM Rapid Run Agarose Bead |
|||
| CMRR-25 | ABTBeads | 25 ml | EUR 102 |
CM Rapid Run Agarose Bead |
|||
| CMRR-300 | ABTBeads | 300 ml | EUR 492 |
 SP Rapid Run Agarose Bead |
|||
| SPRR-25 | ABTBeads | 25 ml | EUR 102 |
SP Rapid Run Agarose Bead |
|||
| SPRR-300 | ABTBeads | 300 ml | EUR 492 |
) Protein A/G Tell-Tale Gold Ribbon Sample Pack, 3 x (1 cm x 30 cm) |
|||
| TTGAG-SP3-B090 | BioAssayWorks | 3 x (1 cm x 30 cm) | EUR 227.67 |
|
|||
|
Description: The pack contains polyester ribbon, which is soaked with 3 different concentrations with Protein A and G conjugated to gold nanoparticles. |
|||
 Replacement generator pack |
|||
| D1000-M5 | BenchMark | 1 PC | EUR 531.32 |
|
|||
Replacement generator pack |
|||
| D1000-M7 | BenchMark | 1 PC | EUR 415.61 |
|
|||
 0.2ml Adapter pack |
|||
| C1008-A2-6 | BenchMark | 1 PC | EUR 84.94 |
|
|||
0.2ml Adapter pack |
|||
| C1008-A2-9 | BenchMark | 1 PC | EUR 395.96 |
|
|||
 0.5ml Adapter pack |
|||
| C1008-A5-6 | BenchMark | 1 PC | EUR 80.95 |
|
|||
0.5ml Adapter pack |
|||
| C1008-A5-8 | BenchMark | 1 PC | EUR 84.94 |
|
|||
 mini cooling pack |
|||
| EVS1100-COOL | Consort | ea | EUR 48 |
 maxi cooling pack |
|||
| EVS1300-COOL | Consort | ea | EUR 82 |
 Safe-Pack™ |
|||
| G108-P | ABM | G108-WGR | EUR 104 |
) Spatulas (Large Pack) |
|||
| SPAT1 | Next Advance | 50pack | EUR 301 |
|
Description: Individually wrapped spatulas. RNase/DNase free, non-pyrogenic, antistatic, sterile, plastic. Pack of 50. |
|||
) Spatulas (Small Pack) |
|||
| SPAT2 | Next Advance | 10pack | EUR 133 |
|
Description: Individually wrapped spatulas. RNase/DNase free, non-pyrogenic, antistatic, sterile, plastic. Pack of 10. |
|||
 CometAssay HT Sample Kit |
|||
| 4252-040-K | Biotechne | 40 Tests | EUR 428 |
 Deproteinizing Sample Preparation Kit |
|||
| 55R-1542 | Fitzgerald | 200 assays | EUR 450 |
|
Description: Deproteinizing Sample Preparation Kit for use in the research laboratory |
|||
 Salivary Sample Collection Kit |
|||
| 55R-IB76305 | Fitzgerald | 500 tests | EUR 301 |
|
Description: Salivary sample collection kit for the detection of free Salivary proteins and enzymes in the research laboratory |
|||
 comb 10 sample, 0.8mm |
|||
| EVS3100-C10-0.8 | Consort | ea | EUR 59 |
 comb 10 sample, 1.5mm |
|||
| EVS3100-C10-1.5 | Consort | ea | EUR 59 |
 comb 12 sample, 0.8mm |
|||
| EVS3100-C12-0.8 | Consort | ea | EUR 59 |
 comb 12 sample, 1.5mm |
|||
| EVS3100-C12-1.5 | Consort | ea | EUR 59 |
 comb 6 sample, 0.8mm |
|||
| EVS3100-C6-0.8 | Consort | ea | EUR 59 |
 comb 6 sample, 1.5mm |
|||
| EVS3100-C6-1.5 | Consort | ea | EUR 59 |
 comb 8 sample, 0.8mm |
|||
| EVS3100-C8-0.8 | Consort | ea | EUR 59 |
 comb 8 sample, 1.5mm |
|||
| EVS3100-C8-1.5 | Consort | ea | EUR 59 |
comb 10 sample, 0.8mm |
|||
| EVS3200-C10-0.8 | Consort | ea | EUR 65 |
comb 10 sample, 1.5mm |
|||
| EVS3200-C10-1.5 | Consort | ea | EUR 65 |
 comb 15 sample, 0.8mm |
|||
| EVS3200-C15-0.8 | Consort | ea | EUR 65 |
 comb 15 sample, 1.5mm |
|||
| EVS3200-C15-1.5 | Consort | ea | EUR 65 |
 comb 20 sample, 0.8mm |
|||
| EVS3200-C20-0.8 | Consort | ea | EUR 65 |
 comb 20 sample, 1.5mm |
|||
| EVS3200-C20-1.5 | Consort | ea | EUR 65 |
 comb 25 sample, 0.8mm |
|||
| EVS3200-C25-0.8 | Consort | ea | EUR 65 |
 comb 25 sample, 1.5mm |
|||
| EVS3200-C25-1.5 | Consort | ea | EUR 65 |
comb 10 sample, 0.8mm |
|||
| EVS3300-C10-0.8 | Consort | ea | EUR 65 |
comb 10 sample, 1.5mm |
|||
| EVS3300-C10-1.5 | Consort | ea | EUR 65 |
comb 15 sample, 0.8mm |
|||
| EVS3300-C15-0.8 | Consort | ea | EUR 65 |
comb 15 sample, 1.5mm |
|||
| EVS3300-C15-1.5 | Consort | ea | EUR 65 |
Diagnostiske mønstre af ikke-småcellet lungekræft ved Princess Margaret Most cancers Heart
Background: Correct classification of lung most cancers subtypes has change into important in tailoring lung most cancers remedy. Our examine aimed to guage modifications in diagnostic testing and pathologic subtyping of superior non-small-cell lung most cancers (NSCLC) over time at a serious most cancers centre.
Strategies: In a evaluate of sufferers identified with superior NSCLC at Princess Margaret Most cancers Centre between 2007-2009 and 2013-2015, diagnostic methodology, pattern kind and web site, pathologic subtype, and use of immunohistochemistry (IHC) staining and molecular testing had been abstracted.
Outcomes: The evaluate recognized 238 sufferers in 2007-2009 and 283 sufferers in 2013-2015. Over time, the proportion of sufferers identified with adenocarcinoma elevated to 73.1% from 60.9%, and diagnoses of NSCLC not in any other case specified (NOS) decreased to six.4% from 18.9%, p < 0.0001.
Use of diagnostic bronchoscopy decreased (26.9% vs. 18.4%), and mediastinal sampling procedures, together with endobronchial ultrasonography, elevated (9.2% vs. 20.5%, p = 0.0001). Use of IHC elevated over time to 76.3% from 41.6% (p < 0.0001). Bigger surgical or core biopsy samples and people for which IHC was carried out had been extra more likely to bear biomarker testing (each p < 0.01).
Conclusions: Customizing remedy based mostly on pathologic subtype and molecular genotype has change into key in treating sufferers with superior lung most cancers. Better accuracy of pathology prognosis is being achieved, together with by means of the routine use of IHC.
Multi-center implementering af et uddannelsesprogram til forbedring af diagnosticeringsnøjagtigheden for hjertestop hos ambulance-telekommunikatorer og overlevelsesresultater for pludselige hjertestopofre: EduCATe-undersøgelsens design og metode
Background: Sudden cardiac demise stays a number one explanation for mortality in Canada, leading to greater than 35,000 deaths yearly. Most cardiac arrest victims collapse in their very own residence (85% of the time) and 50% are witnessed by a member of the family or bystander. Survivors have a high quality of life much like the overall inhabitants, however the general survival fee for out-of-hospital cardiac arrest (OHCA) hardly ever exceeds 8%.
Victims are virtually 4 instances extra more likely to survive when receiving bystander CPR, however bystander CPR charges have remained low in Canada over the previous decade, not exceeding 15-25% till just lately.
Telecommunication-assisted CPR directions have been proven to considerably improve bystander CPR charges, however agonal respiration could also be misinterpreted as an indication of life by 9-1-1 callers and telecommunicators, and is chargeable for as a lot as 50% of missed OHCA diagnoses. We sought to enhance the flexibility and pace with which ambulance telecommunicators can acknowledge OHCA over the cellphone, provoke well timed CPR directions, and enhance survival.
Strategies: On this multi-center nationwide examine, we are going to implement and consider an academic program developed for ambulance telecommunicators utilizing a a number of baseline interrupted time-series design.
We are going to evaluate outcomes 12 months earlier than and after the implementation of a 20-min theory-based instructional video addressing obstacles to recognition of OHCA whereas within the presence of agonal respiration. Collaborating Canadian websites demonstrated prior potential to gather standardized knowledge on OHCA.
Knowledge shall be collected from eligible 9-1-1 recordings, paramedic documentation and hospital medical information. Eligible circumstances will embrace suspected or confirmed OHCA of presumed cardiac origin in sufferers of any age with tried resuscitation.
Dialogue: The power of telecommunication-assisted CPR directions to enhance bystander CPR and survival charges for OHCA victims is simple. The power of telecommunicators to acknowledge OHCA over the cellphone is unequivocally impeded by relative lack of coaching on agonal respiration, and reluctance to provoke CPR directions when unsure. Our pilot knowledge suggests the potential influence of this challenge shall be to extend absolute OHCA recognition and bystander CPR charges by a minimum of 10%, and absolute out-of-hospital cardiac arrest survival by 5% or extra.
Trial registration: Prospectively registered on March 28, 2019 at ClinicalTrials.gov identifier: NCT03894059 .
Key phrases: Agonal respiration; Cardiac arrest; Cardiopulmonary resuscitation; Emergency medical providers; Resuscitation; Telecommunicators.
 Attoglow Western Blot Analysis Kit- with Millennium Enhancer, Anti chicken secondary antibody |
|||
| K3171120-III | Biochain | 1200 cm2 | EUR 246 |
|
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
|||
Attoglow Western Blot Analysis Kit- with Millennium Enhancer, Anti chicken secondary antibody |
|||
| K3171250-III | Biochain | 2500 cm2 | EUR 310 |
|
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
|||
 Mounting Medium |
|||
| 4300 | Virostat | 3 ml | EUR 180.5 |
|
Description: This is Mounting medium (non-fading) used for maintaining optimal conditions needed to obtain the maximum fluorescence emission from Fluorescein. |
|||
 VALI Medium |
|||
| 450 | AthenaES | 500 ml | EUR 265 |
 BEGM Medium |
|||
| 451 | AthenaES | 500 ml | EUR 152 |
 DC MEDIUM |
|||
| D04-117-10kg | Alphabiosciences | 10 kg | EUR 1579 |
DC MEDIUM |
|||
| D04-117-2kg | Alphabiosciences | 2kg | EUR 382 |
DC MEDIUM |
|||
| D04-117-500g | Alphabiosciences | 500 g | EUR 140 |
 EC MEDIUM |
|||
| E05-100-10kg | Alphabiosciences | 10 kg | EUR 814 |
EC MEDIUM |
|||
| E05-100-2Kg | Alphabiosciences | 2 Kg | EUR 216 |
EC MEDIUM |
|||
| E05-100-500g | Alphabiosciences | 500 g | EUR 95 |
 Advanced Medium |
|||
| C0003-04 | Addexbio | RT 500 mL Bottle | EUR 103 |
 Medium 199 |
|||
| C0012-01 | Addexbio | RT 500 mL Bottle | EUR 105 |
 COLIFORM MEDIUM |
|||
| C03-127-10kg | Alphabiosciences | 10 kg | EUR 1324 |
COLIFORM MEDIUM |
|||
| C03-127-2kg | Alphabiosciences | 2kg | EUR 327 |
COLIFORM MEDIUM |
|||
| C03-127-500g | Alphabiosciences | 500 g | EUR 125 |
 Heller's Medium |
|||
| CP014-010 | GenDepot | 10X1L | EUR 99 |
Heller's Medium |
|||
| CP014-500 | GenDepot | 50L | EUR 126 |
 Hoagland's Medium |
|||
| CP015-010 | GenDepot | 10X1L | EUR 99 |
Hoagland's Medium |
|||
| CP015-500 | GenDepot | 50L | EUR 126 |
 HLP MEDIUM |
|||
| H08-107-10kg | Alphabiosciences | 10 kg | EUR 2278 |
HLP MEDIUM |
|||
| H08-107-2Kg | Alphabiosciences | 2 Kg | EUR 534 |
HLP MEDIUM |
|||
| H08-107-500g | Alphabiosciences | 500 g | EUR 182 |
 NeuroProgenitor Medium |
|||
| NM42400 | Neuromics | 125 ml | EUR 304 |
 SIM MEDIUM |
|||
| S19-110-10kg | Alphabiosciences | 10 kg | EUR 1021 |
SIM MEDIUM |
|||
| S19-110-2kg | Alphabiosciences | 2kg | EUR 261 |
SIM MEDIUM |
|||
| S19-110-500g | Alphabiosciences | 500 g | EUR 107 |
 SOB MEDIUM |
|||
| S19-124-10kg | Alphabiosciences | 10 kg | EUR 965 |
SOB MEDIUM |
|||
| S19-124-2kg | Alphabiosciences | 2kg | EUR 249 |
SOB MEDIUM |
|||
| S19-124-500g | Alphabiosciences | 500 g | EUR 104 |
 A Medium |
|||
| DJ1018 | Bio Basic | 100g | EUR 84.8 |
|
|||
 M9 Medium |
|||
| SD7024 | Bio Basic | 250g | EUR 71.75 |
|
|||
 M9CA Medium |
|||
| SD7025 | Bio Basic | 250g | EUR 71.75 |
|
|||
 YM Medium |
|||
| SD7031 | Bio Basic | 250g | EUR 70.45 |
|
|||
 TYGPN Medium |
|||
| SD7032 | Bio Basic | 250g | EUR 70.01 |
|
|||
 M63 Medium |
|||
| SD7033 | Bio Basic | 250g | EUR 71.75 |
|
|||
 Insect Cell Medium: TNM-FH Insect Culture Medium |
|||
| ABP-MED-10001 | Allele Biotech | 1 liter | Ask for price |
|
|||
 Insect Cell Medium: Serum-Free Insect Culture Medium |
|||
| ABP-MED-10002 | Allele Biotech | 1 liter | Ask for price |
|
|||
) Insect Cell Medium: Grace?s Insect Medium (Unsupplemented) |
|||
| ABP-MED-10004 | Allele Biotech | 1 liter | Ask for price |
|
|||
 EverBrite Mounting Medium |
|||
| 23001 | Biotium | 10mL | EUR 178 |
|
Description: Minimum order quantity: 1 unit of 10mL |
|||
 Recovery Medium - 6x12mL |
|||
| 1711 | Intact Genomics | 4/PK | EUR 128 |
 SuperMOUNT? Mounting Medium |
|||
| 1211-20 | Biovision | EUR 201 | |
 Aqueous Mounting Medium |
|||
| AR1018 | BosterBio | 10mL X5 (Enough for 800-1200 assays) | EUR 80 |
 Antifade Mounting Medium |
|||
| AR1109 | BosterBio | 10mL (for 1000 assays) | EUR 65 |
 EC MEDIUM, MODIFIED |
|||
| E05-108-10kg | Alphabiosciences | 10 kg | EUR 858 |
EC MEDIUM, MODIFIED |
|||
| E05-108-2Kg | Alphabiosciences | 2 Kg | EUR 226 |
EC MEDIUM, MODIFIED |
|||
| E05-108-500g | Alphabiosciences | 500 g | EUR 98 |
 A-1 MEDIUM |
|||
| A01-116-10kg | Alphabiosciences | 10 kg | EUR 1034 |
A-1 MEDIUM |
|||
| A01-116-2Kg | Alphabiosciences | 2 Kg | EUR 264 |
A-1 MEDIUM |
|||
| A01-116-500g | Alphabiosciences | 500 g | EUR 108 |
 RPMI 1640 Medium |
|||
| abx098879-500ml | Abbexa | 500 ml | EUR 175 |
|
|||
 MCDB 131 Medium |
|||
| CM034-050 | GenDepot | 500ml | EUR 85 |
MCDB 131 Medium |
|||
| CM034-300 | GenDepot | 6x500ml | EUR 165 |
MCDB 131 Medium |
|||
| CM034-310 | GenDepot | 10x500ml | EUR 219 |
MCDB 131 Medium |
|||
| CM034-320 | GenDepot | 20x500ml | EUR 340 |
MCDB 131 Medium |
|||
| CM034-350 | GenDepot | 50x500ml | EUR 585 |
 Williams' Medium E |
|||
| CM063-050 | GenDepot | 500ml | EUR 91 |
Williams' Medium E |
|||
| CM063-300 | GenDepot | 6x500ml | EUR 266 |
Williams' Medium E |
|||
| CM063-310 | GenDepot | 10x500ml | EUR 313 |
Williams' Medium E |
|||
| CM063-320 | GenDepot | 20x500ml | EUR 604 |
Williams' Medium E |
|||
| CM063-350 | GenDepot | 50x500ml | EUR 975 |
 AddexBio Cryopreservation Medium |
|||
| C0002-20mL | Addexbio | RT vial | EUR 104 |
 CARY & BLAIR MEDIUM |
|||
| C03-131-10kg | Alphabiosciences | 10 kg | EUR 2185 |
CARY & BLAIR MEDIUM |
|||
| C03-131-2Kg | Alphabiosciences | 2 Kg | EUR 514 |
CARY & BLAIR MEDIUM |
|||
| C03-131-500g | Alphabiosciences | 500 g | EUR 176 |
 Cereal Crops Medium |
|||
| CP003-005 | GenDepot | 5L | EUR 113 |
Cereal Crops Medium |
|||
| CP003-010 | GenDepot | 10X1L | EUR 169 |
 Kao Michayluk Medium |
|||
| CP017-010 | GenDepot | 10X1L | EUR 99 |
Kao Michayluk Medium |
|||
| CP017-500 | GenDepot | 50L | EUR 126 |
 Orchid Maintenance Medium |
|||
| CP037-010 | GenDepot | 10X1L | EUR 109 |
Orchid Maintenance Medium |
|||
| CP037-500 | GenDepot | 50L | EUR 138 |
 Woody Plants Medium |
|||
| CP040-010 | GenDepot | 10X1L | EUR 101 |
Woody Plants Medium |
|||
| CP040-500 | GenDepot | 50L | EUR 126 |
 Hepatocyte Maintenance Medium |
|||
| HM42600 | Neuromics | 100 ml | EUR 409 |
 Neuron Growth Medium |
|||
| HNM001 | Neuromics | 500 ml | EUR 331 |
 FLUID THIOGLYCOLLATE MEDIUM |
|||
| F06-101-10kg | Alphabiosciences | 10 kg | EUR 792 |
FLUID THIOGLYCOLLATE MEDIUM |
|||
| F06-101-2kg | Alphabiosciences | 2kg | EUR 211 |
FLUID THIOGLYCOLLATE MEDIUM |
|||
| F06-101-500g | Alphabiosciences | 500 g | EUR 94 |
 Agarose, medium EEO |
|||
| GE4750-100G | Glentham Life Sciences | 100 g | EUR 166 |
Agarose, medium EEO |
|||
| GE4750-500G | Glentham Life Sciences | 500 g | EUR 429 |
 FluoreGuard Mounting Medium |
|||
| FMM030 | ScyTek Laboratories | 30 ml | EUR 96 |
FluoreGuard Mounting Medium |
|||
| FMM060 | ScyTek Laboratories | 60 ml | EUR 116 |
FluoreGuard Mounting Medium |
|||
| FMM500 | ScyTek Laboratories | 500 ml | EUR 327 |
FluoreGuard Mounting Medium |
|||
| FMM999 | ScyTek Laboratories | 1000 ml | EUR 530 |
 OF BASAL MEDIUM |
|||
| O15-100-10kg | Alphabiosciences | 10 kg | Ask for price |
OF BASAL MEDIUM |
|||
| O15-100-2kg | Alphabiosciences | 2kg | Ask for price |
OF BASAL MEDIUM |
|||
| O15-100-500g | Alphabiosciences | 500 g | Ask for price |
 MOTILITY TEST MEDIUM |
|||
| M13-121-10kg | Alphabiosciences | 10 kg | EUR 1528 |
MOTILITY TEST MEDIUM |
|||
| M13-121-2Kg | Alphabiosciences | 2 Kg | EUR 371 |
MOTILITY TEST MEDIUM |
|||
| M13-121-500g | Alphabiosciences | 500 g | EUR 137 |
 REINFORCED CLOSTRIDIUM MEDIUM |
|||
| R18-105-10kg | Alphabiosciences | 10 kg | EUR 1194 |
REINFORCED CLOSTRIDIUM MEDIUM |
|||
| R18-105-2kg | Alphabiosciences | 2kg | EUR 299 |
REINFORCED CLOSTRIDIUM MEDIUM |
|||
| R18-105-500g | Alphabiosciences | 500 g | EUR 118 |
 Sepadextran-25 Medium |
|||
| SD25M-100 | ABTBeads | 100 g | EUR 271 |
Sepadextran-25 Medium |
|||
| SD25M-500 | ABTBeads | 500 g | EUR 1036 |
 Sepadextran-50 Medium |
|||
| SD50M-100 | ABTBeads | 100 g | EUR 344 |